Molecular Mechanism of the Effect of Zhizhu Pill on Gastroesophageal Reflux Disease Based on Network Pharmacology and Molecular Docking
Open Access
- 19 May 2022
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-13
Abstract
Background. To investigate the pharmacological mechanism of Zhizhu pill (ZZP) against gastroesophageal reflux disease (GERD), network pharmacology in combination with molecular docking was applied in this study. Methods. Active compounds of ZZP and target genes related to GERD were identified through public databases. Subsequently, the obtained data were used as a basis for further network pharmacological analysis to explore the potential key active compounds, core targets, and biological processes involved in ZZP against GERD. Finally, the results predicted by network pharmacology were validated by molecular docking. Results. Twenty active components of ZZP were identified to act on 59 targets related to GERD. Enrichment analysis revealed that multiple biological processes including response to oxygen levels, response to oxidative stress, and response to reactive oxygen species were involved in the GERD ZZP treatment with ZZP. ZZP had an impact on the prognosis of GERD mainly through the HIF-1 signaling pathway, PI3K-Akt signaling pathway, and pathways in cancer. Further analysis identified the key components and core targets of ZZP against GERD, of which nobiletin, didymin, luteolin, and naringenin were key components, and PPARG, MMP9, JUN, TP53, PTGS2, EGFR, MAPK3, CASP3, AKT1, and VEGFA were the core targets. Molecular docking verified the stable bonds formed between the key components and the core targets. Conclusions. The results of this study predict that the therapeutic effects of ZZP in GERD are mediated at least in part via PPARG, MMP9, JUN, TP53, PTGS2, EGFR, MAPK3, CASP3, AKT1, and VEGFA. These results may be useful in providing an experimental basis and new ideas for further research on ZZP in GERD.Keywords
Funding Information
- National Program on Key Research Project (2019YFC17, ZYYCXTD-C-C202010, 82004355, 82004356, CI2021A01001, ZZ14-YQ-002, ZZ14-YQ-005, ZZ15-YQ-014)
- State Administration of Traditional Chinese Medicine Digestive Refractory Disease Inheritance and Innovation Team Project (2019YFC17, ZYYCXTD-C-C202010, 82004355, 82004356, CI2021A01001, ZZ14-YQ-002, ZZ14-YQ-005, ZZ15-YQ-014)
- National Natural Science Foundation of China (2019YFC17, ZYYCXTD-C-C202010, 82004355, 82004356, CI2021A01001, ZZ14-YQ-002, ZZ14-YQ-005, ZZ15-YQ-014)
- China Academy of Chinese Medical Sciences (2019YFC17, ZYYCXTD-C-C202010, 82004355, 82004356, CI2021A01001, ZZ14-YQ-002, ZZ14-YQ-005, ZZ15-YQ-014)
This publication has 49 references indexed in Scilit:
- Supplemental Naringenin Prevents Intestinal Barrier Defects and Inflammation in Colitic MiceThe Journal of Nutrition, 2013
- Increase of Epidermal Growth Factor Receptor Expression in Progression of GERD, Barrett, and Adenocarcinoma of EsophagusDigestive Diseases and Sciences, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitorsCurrent Opinion in Gastroenterology, 2010
- Drug—target networkNature Biotechnology, 2007
- Network pharmacologyNature Biotechnology, 2007
- Inflammation and Oxidative Stress in Gastroesophageal Reflux DiseaseJournal of Clinical Biochemistry and Nutrition, 2007
- Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphomaCarcinogenesis, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Oxidative stress has a role in malignant transformation in Barrett's oesophagusInternational Journal of Cancer, 2002